loading

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
10.24%
30.98
28.10 32.87 26.37 43.98
Operating Expenses
11.03%
27.99
31.46 29.79 28.35 29.77
Interest Income/Expense
7.63%
0.141
0.131 0.001 0.284 0.24
Benefits Costs and Expenses
849.45%
-82.47
11.00 45.01 23.20 -11.56
Costs And Expenses
849.45%
-82.47
11.00 45.01 23.20 -11.56
Operating Income/Loss
188.98%
2.988
-3.358 3.078 -1.983 14.21
Nonoperating Income/Loss
440.01%
110.46
20.45 -15.22 5.154 41.33
Income/Loss Before Equity Method Investments
115.80
- - - -
Income/Loss From Equity Method Investments
-2.352
- - - -
Income/Loss From Continuing Operations Before Tax
563.55%
113.45
17.10 -12.14 3.171 55.54
Income Tax Expense/Benefit
2,603%
27.31
-1.091 -1.871 0.881 11.92
Income/Loss From Continuing Operations After Tax
373.60%
86.14
18.19 -10.27 2.29 43.61
Income/Loss From Discontinued Operations, Net Of Tax
-
- - - -1.665
Net Income/Loss
373.60%
86.14
18.19 -10.27 2.29 41.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
31,009%
17.73
0.057 17.38 17.28 17.06
Diluted Average Shares
67,219%
18.12
-0.027 17.38 17.73 17.97
Basic Earnings Per Share
362.86%
4.86
1.05 -0.59 0.13 2.46
Diluted Earnings Per Share
361.17%
4.75
1.03 -0.59 0.13 2.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):